Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Domenico Motola"'
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0139097 (2015)
ObjectivesTo evaluate antibiotic consumption in the pediatric wards of Emilia-Romagna Region, from 2004 to 2011, with a focus on the antibiotics reserved to the most serious infections, and to analyse the ADRs reported for antibiotics by the pediatri
Externí odkaz:
https://doaj.org/article/6e3b65175f1b49a5982cff36a8a6a0d9
Autor:
Greta Santi Laurini, Nicola Montanaro, Massimiliano Broccoli, Giulia Bonaldo, Domenico Motola
Publikováno v:
Vaccine. 41:2879-2886
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1fdd32bde422a22de66ce3c9175d3a
https://doi.org/10.1016/j.vaccine.2023.03.054
https://doi.org/10.1016/j.vaccine.2023.03.054
Publikováno v:
European Journal of Clinical Pharmacology. 79:657-661
Purpose Since vaccination against COVID-19 is recommended in pregnant people, we aimed to provide further evidence on the safety profile of COVID-19 vaccines in pregnancy. Methods Data on COVID-19 vaccines adverse events following immunizations (AEFI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1365c8a0f9c040984291abcfb2df4a61
https://doi.org/10.1007/s00228-023-03482-8
https://doi.org/10.1007/s00228-023-03482-8
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:2130-2139
Migraine is one of the most prevalent and disabling medical illnesses. Preventive drugs are used to reduce the frequency, severity, and duration of attacks. Most patients were no longer on their medication due to contraindications or poor clinical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1272391ec4b2d296e616edd41e43f158
https://doi.org/10.1111/jcpt.13760
https://doi.org/10.1111/jcpt.13760
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Two chimeric antigen receptor T-cell (CAR-T) therapies have been approved in the United States (USA) in 2017 and Europe (EU) in 2018: axicabtagene ciloleucel and tisagenlecleucel. They contain the patient’s own T cells, which are extracted,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba76d18c1809ea9259c08be080c10d34
https://doi.org/10.1007/s00228-021-03106-z
https://doi.org/10.1007/s00228-021-03106-z
Publikováno v:
Fundamentalclinical pharmacologyREFERENCES. 36(6)
At the beginning of the COVID-19 pandemic, worldwide attempts were made to identify potential drugs effective against the COVID-19. Hydroxychloroquine was among the first receiving attention. However, following its use in therapy, it has been shown t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61cc5aca7d892d0996d2669e9cc9dff4
https://pubmed.ncbi.nlm.nih.gov/35526987
https://pubmed.ncbi.nlm.nih.gov/35526987
Publikováno v:
British Journal of Clinical Pharmacology. 87:1912-1917
Aims: Human papilloma virus (HPV) is 1 of the most common sexually transmitted infection responsible for different types of cancer: cervical, penile, vulvar, anal and oropharyngeal. It can affect both males and females. Our aim was to enrich the know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8c4539bb5dd2326d7d7fe9d9401298
https://doi.org/10.1111/bcp.14584
https://doi.org/10.1111/bcp.14584
Publikováno v:
Br J Clin Pharmacol
Little is known about the administration of direct-acting oral anticoagulants (DOACs) and the occurrence of alopecia. Our aim was to analyse the reports of alopecia following DOAC administration received until 2 May 2018 from VigiBase, the World Heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f94d4bb3302533ce71e1fcc90c7a8885
https://doi.org/10.1111/bcp.14221
https://doi.org/10.1111/bcp.14221
Publikováno v:
European Journal of Clinical Pharmacology. 75:1415-1420
Purpose In Italy, the non-commercial trials on medicines are regulated by the Ministry Decree 17 December, 2004. Its intent is of encouraging the independent research for the improvement of clinical practice. We aimed to analyze the main features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3433c64b3e9927427da6997789f796f3
https://doi.org/10.1007/s00228-019-02706-0
https://doi.org/10.1007/s00228-019-02706-0
Publikováno v:
European journal of clinical pharmacology. 77(7)
Purpose: Various incentives are provided by the European Medicines Agency (EMA) to facilitate the development and marketing of orphan drugs. A 10-year period of market exclusivity is reserved to an orphan medicinal product. Sometimes, the sponsor ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702d878c6b9347968a4c7c20f533e615
https://pubmed.ncbi.nlm.nih.gov/33501508
https://pubmed.ncbi.nlm.nih.gov/33501508